STOCK TITAN

Nova Ltd. Form 4 Filings

NVMI NASDAQ

Every Form 4 that Nova Ltd. (NVMI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow NVMI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NVMI filings page.

Rhea-AI Summary

NOVA LTD. (NVMI) reports that CEO & President Gabriel Waisman sold 1,500 ordinary shares on September 1, 2026 at $342.27 per share in an open-market or private transaction made under a Rule 10b5-1 trading plan. Following this sale, he holds 27,214 ordinary shares directly, including 12,320 currently held shares and 14,894 Restricted Stock Units (RSUs) scheduled to vest in equal annual installments through 2030, each RSU representing one ordinary share upon vesting and settlement.

Rhea-AI Summary

NOVA LTD. (symbol: NVMI) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

NOVA LTD. (symbol: NVMI) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

NOVA LTD. CEO & President Gabriel Waisman reported an open-market sale of 2,966 ordinary shares on July 2, 2026 at $501.30 per share. After this transaction, he directly holds 28,714 ordinary shares. His position also includes multiple tranches of restricted share units that vest annually through 2030, each convertible into one ordinary share upon vesting and settlement. The sale represents a partial trim of his stake while maintaining a substantial ongoing equity interest in the company.

Rhea-AI Summary

Waisman Gabriel reported acquisition or exercise transactions in this Form 4 filing.

NOVA LTD. CEO and President Gabriel Waisman received a grant of 7,056 ordinary shares on July 1, 2026 at no cost as part of his equity compensation. Following this award, he directly owns 31,680 ordinary shares, along with multiple restricted share units and performance stock units that vest annually through 2030 under the company’s 2017 Share Incentive Plan.

Rhea-AI Summary

Director Yaniv Garty of NOVA LTD. sold 366 ordinary shares in an open-market transaction at $581.20 per share. Following this sale, he directly owns 2,006 ordinary shares, which include multiple restricted share unit awards scheduled to vest in stages through 2027 and 2028.

Rhea-AI Summary

NOVA LTD. director Zehava Simon reported two open-market sales of Ordinary Shares. She sold 454 shares at $536.52 on June 23, 2026 and 366 shares at $581.20 on June 22, 2026, for a total of 820 shares sold. After these transactions, she directly holds 1,951 shares, along with multiple unvested restricted share unit awards scheduled to vest between 2026 and 2028.

Rhea-AI Summary

NOVA LTD. director Sarit Sagiv sold 820 ordinary shares of NVMI in two open-market transactions. The sales occurred on June 22, 2026 and June 23, 2026 at prices of $581.20 and $536.52 per share.

After these transactions, Sagiv directly holds 1,951 ordinary shares. Footnotes indicate additional equity exposure through restricted share units, including blocks of 454, 426, 546, 827 and 334 RSUs that have vested or are scheduled to vest in installments through 2028.

Rhea-AI Summary

NOVA LTD. director Eitan Oppenhaim reported an open-market sale of 1,290 Ordinary Shares at $581.20 per share. After this transaction, he directly holds 6,421 Ordinary Shares.

In addition, he has several restricted share unit (RSU) awards that may convert into Ordinary Shares as they vest through 2027 and 2028.

Rhea-AI Summary

Sagiv Sarit reported acquisition or exercise transactions in this Form 4 filing.

NOVA LTD. director Sagiv Sarit received an equity award of 334 ordinary shares on June 18, 2026, recorded at no cash cost per share. Following this grant, Sarit directly holds 2,771 ordinary shares, combining vested shares and multiple restricted share unit (RSU) awards.

The position includes RSUs that vest in equal annual installments through 2028, with 827 RSUs fully vesting on June 18, 2026 and additional blocks of 454, 426, 546 and 334 RSUs scheduled to vest in future years, subject to continued service.

Rhea-AI Summary

COHEN AVI reported acquisition or exercise transactions in this Form 4 filing.

NOVA LTD. director Avi Cohen reported receiving an equity grant of 334 ordinary-share RSUs on June 18, 2026. The award was granted at no cash cost to him and increases his direct holdings to 8,702 ordinary shares and RSUs combined.

The new 334 RSUs are scheduled to vest in full on June 18, 2027, if he continues providing service to the company. Existing RSU awards are structured to vest in equal annual installments through 2026, 2027 and 2028, aligning his compensation with ongoing service over several years.

Rhea-AI Summary

Simon Zehava reported acquisition or exercise transactions in this Form 4 filing.

NOVA LTD. director Zehava Simon received a routine equity award. On June 18, 2026, she was granted 334 ordinary shares at a price of $0.00 per share as a compensation-related award, not an open-market purchase.

After this grant, her direct holdings total 2,771 ordinary shares. This includes 184 shares plus multiple tranches of restricted share units (RSUs) that vest annually through 2028, with 827 RSUs fully vesting on June 18, 2026 and the new 334 RSUs scheduled to vest in full on June 18, 2027, subject to continued service.

Rhea-AI Summary

Cohen Raanan reported acquisition or exercise transactions in this Form 4 filing.

NOVA LTD. director Raanan Cohen received an equity grant of 334 ordinary shares on June 18, 2026 at no cost as a share-based award. After this grant, his directly held position reported in the filing is 6,048 ordinary shares, including previously granted restricted share units that vest over several years.

Rhea-AI Summary

Garty Yaniv reported acquisition or exercise transactions in this Form 4 filing.

NOVA LTD. director Yaniv Garty received a grant of 334 ordinary shares on June 18, 2026 as a share award, at no cash price. After this grant, he reports beneficial ownership of 2,372 ordinary shares, including multiple blocks of restricted share units that vest annually through 2028.

Rhea-AI Summary

NOVA LTD. director Eitan Oppenhaim received an equity award of 1,043 ordinary shares on June 18, 2026, recorded at no cash price as a grant. After this award, he directly holds 7,711 ordinary shares, including both currently held shares and restricted share units that convert into shares as they vest through 2028.

Rhea-AI Summary

Waisman Gabriel reported acquisition or exercise transactions in this Form 4 filing.

NOVA LTD. CEO and President Gabriel Waisman received 3,000 ordinary shares as a stock-based award. The shares were issued at no cash cost upon settlement and vesting of a performance stock unit granted under the company’s 2017 Share Incentive Plan after achievement of a performance condition on June 1, 2026.

Following this award, Waisman directly holds 24,624 ordinary shares, a figure that includes previously held shares and multiple tranches of restricted share units scheduled to vest annually through 2029, each RSU delivering one ordinary share upon vesting and settlement.

Rhea-AI Summary

NOVA LTD. director Eitan Oppenhaim reported an open-market sale of 1,504 ordinary shares on May 26, 2026 at an average price of $519.48 per share. Following the transaction, he directly holds 6,668 ordinary shares.

Footnotes state these holdings include 646 ordinary shares and several blocks of restricted share units (RSUs): 1,504 RSUs vesting annually through 2027, 1,932 RSUs vesting annually through 2028, and 2,586 RSUs scheduled to vest on June 18, 2026, each RSU convertible into one ordinary share upon vesting and settlement.

Rhea-AI Summary

NOVA LTD. director Sagiv Sarit reported an open-market sale of 426 Ordinary Shares on May 18, 2026 at an average price of $514.49 per share. After the sale, Sarit directly holds 2,437 Ordinary Shares.

In addition to those shares, Sarit has multiple outstanding restricted share unit (RSU) awards. These include 454 RSUs vesting in equal annual installments through 2026, 426 RSUs vesting through 2027, 546 RSUs vesting through 2028, and 827 RSUs that are scheduled to fully vest on June 18, 2026, each RSU representing one Ordinary Share upon vesting and settlement.

Rhea-AI Summary

Nova Ltd. director Zehava Simon reported an open-market sale of 426 ordinary shares at $514.49 per share on May 18, 2026. After this transaction, Simon holds 2,437 shares directly, including ordinary shares and several RSU awards scheduled to vest through 2028.

Rhea-AI Summary

NOVA LTD. director Yaniv Garty completed an open-market sale of 426 ordinary shares at $514.49 per share. After this sale, he directly holds 2,038 ordinary shares. His position also includes multiple restricted share unit awards that vest annually through 2028 and one grant vesting on June 18, 2026.

Rhea-AI Summary

NOVA LTD. director Yaniv Garty reported an open-market sale of 55 Ordinary Shares on April 2, 2026 at $425.00 per share. After this transaction, he directly holds 2,464 shares, including 184 ordinary shares and multiple restricted share unit (RSU) awards.

The RSU holdings include 55 RSUs, 852 RSUs, and 546 RSUs scheduled to vest in equal annual installments through 2027 and 2028, and an additional 827 RSUs that are scheduled to vest in full on June 18, 2026, all contingent on continued service.